PharmTech News

Articles

MGB Biopharma, a biopharmaceutical company specializing in the development of novel anti-infectives to antibiotic resistance, has been named a winner in the 2015 Scottish Business Insider Deals & Dealmakers Awards.

MGB Biopharma Wins Scottish Business Award

Lannett Company agreed to purchase Kremers Urban Pharmaceuticals, the US specialty generic-pharmaceuticals subsidiary of global biopharmaceuticals company UCB S.A., for $1.23 billion.

Lannett Expands Generics with Purchase of Kremers Urban

Mumbai-based Cipla agreed to acquire US companies InvaGen and Exelan, giving Cipla US tablet and capsule production capacity, a more diversified portfolio, and market access.

Cipla Acquires US Companies InvaGen and Exelan

Aragen Bioscience has licensed ProteoNic Biotechnology’s 2G UNic recombinant protein production technology, which increases manufacturing efficiency and reduces cost of goods for recombinant biologicals.

Aragen Bioscience Licenses Protein Production Technology

Tuzistra XR for cough relief is said to be the only twice-daily, extended-release codeine-based cough and cold syrup available in the US.

Vernalis Launches Extended-Release Cough Relief Syrup

The partners will collaborate on a project to capture and integrate clinical trial data metrics on investigational cancer medications.

AstraZeneca and the University of Manchester Team Up on Bioinformatics Venture

Pfizer closes the acquisition of Hospira, adding sterile injectables business to portfolio.

Pfizer Completes Acquisition of Hospira

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

After many legal proceedings surrounding the first FDA-approved biosimilar, Zarxio officially launched commercially on Sept. 3, 2015.

Sandoz Officially Launches Zarxio

The investigational monoclonal antibody targets interleukin-17 and is in clinical trials for the treatment of plaque psoriasis.

Valeant Licenses Brodalumab Candidate from AstraZeneca

UPS joins the Global Health Supply Chain Technical Assistance program to help secure the drug supply chain.

Bio/Pharma News